abstract |
A benzimidazole compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein X is a 5-membered heteroaryl group selected from the following. The compound has activity in modulating p300 and/or CBP activity and is useful in the treatment of cancer, particularly prostate cancer. |